Carter's plays defense with a poison pill to prevent a hostile takeover
Source: SeekingAlpha
2025-09-24 06:51:58 ET
More on Carter's
- Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming
- Carter's: Going Against The Market's Narrative As Sales Turn
- Carter's, Inc. (CRI) Q2 2025 Earnings Conference Call Transcript
- Carter’s targets price increases and store optimization amid $125M–$150M annual tariff headwind
- U.S. import tariffs to impact Carter's profits going ahead; shares tank
Read the full article on Seeking Alpha
For further details see:
Carter's plays defense with a poison pill to prevent a hostile takeover
Crane Company
NASDAQ: CR
CR Trading
-1.8% G/L:
$172.50 Last:
269,787 Volume:
$174.75 Open:
CR Latest News
March 05, 2026 06:55:00 am
Janus International Group Announces Two Appointments to Its Board of Directors
CR Stock Data
$11,488,275,081
56,375,833
0.98%
236
N/A
Industrial Goods
Industrials
US
Waltham
